Bengal Physician Journal

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Volume  11 (2024)
Volume  10 (2023)
Volume  9 (2022)
Volume  8 (2021)
Volume  7 (2020)
Volume  6 (2019)
Volume  5 (2018)
Related articles

VOLUME 7 , ISSUE 1 ( January-April, 2020 ) > List of Articles

REVIEW ARTICLE

Tacrolimus-associated Pruritus: A Case Report and Review

Shambo S Samajdar

Citation Information : Samajdar SS. Tacrolimus-associated Pruritus: A Case Report and Review. Bengal Physician Journal 2020; 7 (1):12-13.

DOI: 10.5005/jp-journals-10070-7018

License: CC BY-NC 4.0

Published Online: 01-05-2021

Copyright Statement:  Copyright © 2020; The Author(s).


Abstract

The use of immunosuppressants following solid organ transplantation has become a general procedure nowadays. Various immunosuppressants have been used—among them tacrolimus, is a calcineurin inhibitor (CNI) and macrolide antibiotic has been chosen widely. But significant complaints associated with tacrolimus have been reported, for example, severe pruritus. As a result, physicians are required to substitute this one without compromising the intended therapeutic effect, minimizing adverse drug reactions. Everolimus becomes the best alternative, which is also a mammalian target of rapamycin (mTOR) inhibitor with a comparatively wide therapeutic index as compared to tacrolimus. This present reporting is about the tacrolimus-associated pruritus which was severe and how the patient compliance has been ensured keeping in mind the other comorbidities.

HTML PDF Share
  1. Solid organ transplantation in the 21st century. Ann Transl Med 2018;6(20):409. DOI: 10.21037/atm.2018.09.68.
  2. Liver transplantation: immunosuppression and oncology. Curr Opin Organ Transplant 2014;19(3): 253–260.DOI: 10.1097/MOT.0000000000000069.
  3. Sublingual tacrolimus as an alternative to oral administration for solid organ transplant recipients. Am J Health Syst Pharm 2015;72(4): 277–284.DOI: 10.2146/ajhp140322.
  4. Calcineurin inhibitor minimization protocols in liver transplantation. Transpl Int 2009;22(1): 49–60.DOI: 10.1111/j.1432-2277.2008.00796.x.
  5. The side-effects of ciclosporine-A and tacrolimus. Clin Nephrol 1998;49(6):356–363.
  6. Calcineurin inhibitor nephrotoxicity: longitudinal assessment by protocol histology. Transplantation 2004;78(4): 557–565.DOI: 10.1097/01.tp.0000128636.70499.6e.
  7. Combination of everolimus and tacrolimus: a potentially effective regimen for recalcitrant psoriasis. Dermatol Ther 2015;28(1): 25–27.DOI: 10.1111/dth.12176.
  8. Efficacy of sirolimus (rapamycin) administered concomitantly with a subtherapeutic dose of cyclosporin in the treatment of severe psoriasis: a randomized controlled trial. Br J Dermatol 2001:145(3):438–445. DOI: 10.1046/j.1365-2133.2001.04376.x.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.